Subjects With Intestinal Failure Associated Liver Disease Ifald clinical trials

Explore recruiting subjects with intestinal failure associated liver disease ifald clinical trials.

Recruiting subjects with intestinal failure associated liver disease ifald studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Subjects With Intestinal Failure Associated Liver Disease Ifald trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Orziloben (NST-6179) in Subjects with Intestinal Failure-Associated Liver Disease (IFALD)

Belgium, Denmark, France

Therapeutic exploratory (Phase II) EU CTIS Study details

Subjects With Intestinal Failure Associated Liver Disease Ifald trials by city

Subjects With Intestinal Failure Associated Liver Disease Ifald in Toronto Subjects With Intestinal Failure Associated Liver Disease Ifald in Vancouver Subjects With Intestinal Failure Associated Liver Disease Ifald in Montreal Subjects With Intestinal Failure Associated Liver Disease Ifald in Calgary Subjects With Intestinal Failure Associated Liver Disease Ifald in Edmonton Subjects With Intestinal Failure Associated Liver Disease Ifald in Ottawa Subjects With Intestinal Failure Associated Liver Disease Ifald in Winnipeg Subjects With Intestinal Failure Associated Liver Disease Ifald in Quebec City Subjects With Intestinal Failure Associated Liver Disease Ifald in Hamilton Subjects With Intestinal Failure Associated Liver Disease Ifald in Kitchener Subjects With Intestinal Failure Associated Liver Disease Ifald in London Subjects With Intestinal Failure Associated Liver Disease Ifald in Halifax Subjects With Intestinal Failure Associated Liver Disease Ifald in New York Subjects With Intestinal Failure Associated Liver Disease Ifald in Los Angeles Subjects With Intestinal Failure Associated Liver Disease Ifald in Chicago Subjects With Intestinal Failure Associated Liver Disease Ifald in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease